消费者对药物不良反应的报告：允许患者报告其所服用药物的副作用的系统，已为改善药物安全性和医疗保健提供了有价值的信息。
Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care.
作者信息
Weigmann Katrin
机构信息
Oldenburg, Germany.
出版信息
EMBO Rep. 2016 Jul;17(7):949-52. doi: 10.15252/embr.201642616. Epub 2016 May 19.
Abstract
Many countries have established systems that allow patients to report adverse drug reactions directly, complementing the reports from healthcare professionals. Experience with these systems has shown that direct consumer reporting on drug side effects provides valuable information for public health and healthcare authorities. [Image: see text]
摘要
许多国家已建立了允许患者直接报告药物不良反应的系统，作为医疗保健专业人员报告的补充。这些系统的经验表明，消费者直接报告药物副作用可为公共卫生和医疗保健当局提供有价值的信息。[图片：见正文]
相似文献
1
Consumer reporting of adverse drug reactions: Systems that allow patients to report side effects of the drugs they are taking have yielded valuable information for improving drugs safety and health care.消费者对药物不良反应的报告：允许患者报告其所服用药物的副作用的系统，已为改善药物安全性和医疗保健提供了有价值的信息。
EMBO Rep. 2016 Jul;17(7):949-52. doi: 10.15252/embr.201642616. Epub 2016 May 19.
2
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
3
Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.药物基因组学药物警戒：一项药物基因组学药物警戒计划。
Pharmacogenomics. 2014 Apr;15(6):845-56. doi: 10.2217/pgs.14.44.
4
Are consumers ready to take part in the Pharmacovigilance System?--a Portuguese preliminary study concerning ADR reporting.消费者准备好参与药物警戒系统了吗？——一项关于药品不良反应报告的葡萄牙初步研究。
Eur J Clin Pharmacol. 2015 Jul;71(7):883-90. doi: 10.1007/s00228-015-1867-2. Epub 2015 May 26.
5
[Direct reporting by patients of adverse drug reactions in Spain].[西班牙患者对药物不良反应的直接报告]
Farm Hosp. 2013 Jan-Feb;37(1):65-71. doi: 10.7399/FH.2013.37.1.121.
6
Bulgarian Experience with Adverse Drug Reaction Reports from Patients and Consumers - Retrospective Data-base Study.保加利亚患者和消费者药品不良反应报告的经验——回顾性数据库研究
Folia Med (Plovdiv). 2018 Sep 1;60(3):447-453. doi: 10.2478/folmed-2018-0016.
7
French pharmacovigilance: Missions, organization and perspectives.法国药物警戒：任务、组织与展望。
Therapie. 2016 Apr;71(2):143-50. doi: 10.1016/j.therap.2016.02.029. Epub 2016 Feb 20.
8
Using real-world healthcare data for pharmacovigilance signal detection - the experience of the EU-ADR project.利用真实世界医疗保健数据进行药物警戒信号检测——欧盟药物不良反应（EU-ADR）项目的经验
Expert Rev Clin Pharmacol. 2015 Jan;8(1):95-102. doi: 10.1586/17512433.2015.992878.
9
Adverse Drug Reaction Reports Received Through the Mobile App, VigiBIP: A Comparison with Classical Methods of Reporting.通过移动应用程序 VigiBIP 收到的药物不良反应报告：与传统报告方法的比较。
Drug Saf. 2018 May;41(5):511-514. doi: 10.1007/s40264-017-0630-2.
10
Adverse drug reaction reporting: how can drug consumption information add to analyses using spontaneous reports?药品不良反应报告：药物消费信息如何为基于自发报告的分析提供补充？
Eur J Clin Pharmacol. 2018 Apr;74(4):497-504. doi: 10.1007/s00228-017-2396-y. Epub 2017 Dec 18.
引用本文的文献
1
Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase.CAR-T细胞疗法的上市后安全性评估：对VigiBase中个体病例安全报告的分析
Ther Innov Regul Sci. 2025 Jul 21. doi: 10.1007/s43441-025-00826-7.
2
Factors Associated with the Public's Intention to Report Adverse Drug Reactions to Community Pharmacists in the Makkah Region of Saudi Arabia: An Application of the Theory of Planned Behavior.沙特阿拉伯麦加地区公众向社区药剂师报告药品不良反应意愿的相关因素：计划行为理论的应用
Patient Prefer Adherence. 2024 Dec 11;18:2495-2506. doi: 10.2147/PPA.S495487. eCollection 2024.
3
Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey.消费者对澳大利亚药物不良反应报告的了解和经验：一项全国性调查。
Eur J Clin Pharmacol. 2024 Oct;80(10):1543-1554. doi: 10.1007/s00228-024-03729-y. Epub 2024 Jul 12.
4
Exploring Adverse Drug Reactions in Psychotropic Medications: A Retrospective Analysis of Portuguese Pharmacovigilance Data.探索精神药物中的药物不良反应：葡萄牙药物警戒数据的回顾性分析
Healthcare (Basel). 2024 Apr 9;12(8):808. doi: 10.3390/healthcare12080808.
5
Strategies and interventions to strengthen pharmacovigilance systems in low-income and middle-income countries: a scoping review.加强中低收入国家药物警戒系统的策略和干预措施：范围综述。
BMJ Open. 2023 Sep 14;13(9):e071079. doi: 10.1136/bmjopen-2022-071079.
6
Awareness, Actions, and Predictors of Actions on Adverse Drug Reaction Reporting among Patients Attending a Referral Hospital in Southern Highland Tanzania.坦桑尼亚南部高地一家转诊医院患者对药物不良反应报告的认知、行动及行动预测因素
Adv Pharmacol Pharm Sci. 2023 May 9;2023:7761649. doi: 10.1155/2023/7761649. eCollection 2023.
7
Patients' perception of the pharmacovigilance system: A pre-diagnostic and post-interventional cross-sectional survey.患者对药物警戒系统的认知：一项诊断前和干预后的横断面调查。
Front Pharmacol. 2022 Nov 17;13:936124. doi: 10.3389/fphar.2022.936124. eCollection 2022.
8
Parental reporting of adverse drug reactions in South Africa: An online survey.南非的药物不良反应家长报告：一项在线调查。
Afr J Prim Health Care Fam Med. 2021 Sep 29;13(1):e1-e8. doi: 10.4102/phcfm.v13i1.2880.
9
Longitudinal trends and determinants of patient-reported side effects on ART-a Swedish national registry study.抗逆转录病毒治疗相关患者报告副作用的纵向趋势及其决定因素：一项瑞典全国登记研究。
PLoS One. 2020 Dec 23;15(12):e0242710. doi: 10.1371/journal.pone.0242710. eCollection 2020.
10
The Role of European Patient Organizations in Pharmacovigilance.欧洲患者组织在药物警戒中的作用。
Drug Saf. 2019 Apr;42(4):547-557. doi: 10.1007/s40264-018-0748-x.
本文引用的文献
1
ADR Reporting by the General Public: Lessons Learnt from the Dutch and Swedish Systems.公众药品不良反应报告：荷兰和瑞典系统的经验教训
Drug Saf. 2015 Apr;38(4):337-47. doi: 10.1007/s40264-015-0264-1.
2
Adverse drug reaction reporting by patients: an overview of fifty countries.患者上报药品不良反应情况：五十个国家概述
Drug Saf. 2014 Jun;37(6):409-19. doi: 10.1007/s40264-014-0162-y.
3
How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.患者如何有助于信号检测？：英国黄卡计划中自发报告药物不良反应的回顾性分析。
Drug Saf. 2013 Mar;36(3):199-206. doi: 10.1007/s40264-013-0021-2.
4
Experiences from consumer reports on psychiatric adverse drug reactions with antidepressant medication: a qualitative study of reports to a consumer association.消费者报告抗抑郁药精神药物不良反应的经验：向消费者协会报告的定性研究。
BMC Pharmacol Toxicol. 2012 Dec 23;13:19. doi: 10.1186/2050-6511-13-19.
5
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association.我们能从消费者关于抗抑郁药物精神科药物不良反应的报告中学到什么？向消费者协会报告的经验。
BMC Clin Pharmacol. 2011 Oct 25;11:16. doi: 10.1186/1472-6904-11-16.
6
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况：文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
7
Comparing patients' and healthcare professionals' ADR reports after media attention: the broadcast of a Dutch television programme about the benefits and risks of statins as an example.媒体关注后比较患者和医疗保健专业人员的药品不良反应报告：以荷兰一档关于他汀类药物利弊的电视节目播出为例
Br J Clin Pharmacol. 2009 May;67(5):558-64. doi: 10.1111/j.1365-2125.2009.03400.x. Epub 2009 Feb 26.
8
Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance.医生对患者药物不良反应报告的反应：对以患者为目标的不良反应监测的影响。
Drug Saf. 2007;30(8):669-75. doi: 10.2165/00002018-200730080-00003.
Zotero 插件